{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T13:06:45Z","timestamp":1789736805608,"version":"4.0.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:00:00Z","timestamp":1789689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:00:00Z","timestamp":1789689600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["45\/02\/2022 - HUM\/BMS"],"award-info":[{"award-number":["45\/02\/2022 - HUM\/BMS"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-026-12710-0","type":"journal-article","created":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T12:46:02Z","timestamp":1789735562000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Peripheral immune cell expression of IRAK1, TRAF6, MAPK1 and CXCL8 in coronary artery disease"],"prefix":"10.1007","volume":"53","author":[{"given":"Vinodhini","family":"Subramanian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Jeevan","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T R","family":"Muralidharan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2827-8680","authenticated-orcid":false,"given":"Vettriselvi","family":"Venkatesan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,18]]},"reference":[{"key":"12710_CR1","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1186\/s12872-025-05022-x","volume":"25","author":"L Yang","year":"2025","unstructured":"Yang L, Zheng B, Gong Y (2025) Global, regional and national burden of ischemic heart disease and its attributable risk factors from 1990 to 2021: a systematic analysis of the Global Burden of Disease study 2021. BMC Cardiovasc Disord 25:625","journal-title":"BMC Cardiovasc Disord"},{"key":"12710_CR2","first-page":"200200","volume":"19","author":"K Yadav","year":"2023","unstructured":"Yadav K et al (2023) Trend of risk factors for cardiovascular diseases among young and middle-aged indians: Insights from a nationally representative survey. Int J Cardiol Cardiovasc Risk Prev 19:200200","journal-title":"Int J Cardiol Cardiovasc Risk Prev"},{"key":"12710_CR3","doi-asserted-by":"publisher","first-page":"2831","DOI":"10.1093\/eurheartj\/ehac249","volume":"43","author":"P Joseph","year":"2022","unstructured":"Joseph P et al (2022) Cardiovascular disease, mortality, and their associations with modifiable risk factors in a multi-national South Asia cohort: a PURE substudy. Eur Heart J 43:2831\u20132840","journal-title":"Eur Heart J"},{"key":"12710_CR4","doi-asserted-by":"publisher","first-page":"100130","DOI":"10.1016\/j.ajpc.2020.100130","volume":"4","author":"A Alfaddagh","year":"2020","unstructured":"Alfaddagh A et al (2020) Inflammation and cardiovascular disease: From mechanisms to therapeutics. Am J Prev Cardiol 4:100130","journal-title":"Am J Prev Cardiol"},{"key":"12710_CR5","doi-asserted-by":"publisher","first-page":"461","DOI":"10.3389\/fimmu.2014.00461","volume":"5","author":"T Kawasaki","year":"2014","unstructured":"Kawasaki T, Kawai T (2014) Toll-like receptor signaling pathways. Front Immunol 5:461","journal-title":"Front Immunol"},{"key":"12710_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cyto.2007.12.012","volume":"42","author":"L Ringwood","year":"2008","unstructured":"Ringwood L, Li L (2008) The involvement of the interleukin-1 receptor-associated kinases (IRAKs) in cellular signaling networks controlling inflammation. Cytokine 42:1\u20137","journal-title":"Cytokine"},{"key":"12710_CR7","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1038\/nature09121","volume":"465","author":"S-C Lin","year":"2010","unstructured":"Lin S-C, Lo Y-C, Wu H (2010) Helical assembly in the MyD88-IRAK4-IRAK2 complex in TLR\/IL-1R signalling. Nature 465:885\u2013890","journal-title":"Nature"},{"issue":"10","key":"12710_CR8","doi-asserted-by":"publisher","first-page":"e57233","DOI":"10.15252\/embr.202357233","volume":"24","author":"F Cao","year":"2023","unstructured":"Cao F, Deliz-Aguirre R, Gerpott FH, Ziska E, Taylor MJ (2023) Myddosome clustering in IL \u20101 receptor signaling regulates the formation of an NF\u2010kB activating signalosome. EMBO Rep 24(10):e57233","journal-title":"EMBO Rep"},{"key":"12710_CR9","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1161\/01.CIR.101.13.1519","volume":"101","author":"A Simonini","year":"2000","unstructured":"Simonini A et al (2000) IL-8 Is an Angiogenic Factor in Human Coronary Atherectomy Tissue. Circulation 101:1519\u20131526","journal-title":"Circulation"},{"key":"12710_CR10","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.7150\/thno.15625","volume":"7","author":"H Ha","year":"2017","unstructured":"Ha H, Debnath B, Neamati N (2017) Role of the CXCL8-CXCR1\/2 Axis in Cancer and Inflammatory Diseases. Theranostics 7:1543\u20131588","journal-title":"Theranostics"},{"key":"12710_CR11","doi-asserted-by":"crossref","unstructured":"Pereira M, Gazzinelli RT (2023) Regulation of innate immune signaling by IRAK proteins. Front Immunol 14:1133354","DOI":"10.3389\/fimmu.2023.1133354"},{"key":"12710_CR12","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/s41392-020-00312-6","volume":"5","author":"H Yu","year":"2020","unstructured":"Yu H, Lin L, Zhang Z, Zhang H, Hu H (2020) Targeting NF-\u03baB pathway for the therapy of diseases: mechanism and clinical study. Signal Transduct Target Ther 5:209","journal-title":"Signal Transduct Target Ther"},{"key":"12710_CR13","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1186\/s12944-018-0798-1","volume":"17","author":"M Liu","year":"2018","unstructured":"Liu M et al (2018) Peripheral-blood gene expression profiling studies for coronary artery disease and its severity in Xinjiang population in China. Lipids Health Dis 17:154","journal-title":"Lipids Health Dis"},{"key":"12710_CR14","doi-asserted-by":"publisher","first-page":"97","DOI":"10.31083\/j.rcm2303097","volume":"23","author":"Y Zheng","year":"2022","unstructured":"Zheng Y, He J-Q (2022) Interleukin Receptor Associated Kinase 1 Signaling and Its Association with Cardiovascular Diseases. Rev Cardiovasc Med 23:97","journal-title":"Rev Cardiovasc Med"},{"key":"12710_CR15","doi-asserted-by":"crossref","unstructured":"Reina-Couto M et al (2021) Inflammation in human heart failure: Major mediators and therapeutic targets. Front Physiol 12:746494","DOI":"10.3389\/fphys.2021.746494"},{"key":"12710_CR16","doi-asserted-by":"publisher","first-page":"17269","DOI":"10.1038\/s41598-024-68333-7","volume":"14","author":"E Maaniitty","year":"2024","unstructured":"Maaniitty E et al (2024) Differential circulating cytokine profiles in acute coronary syndrome versus stable coronary artery disease. Sci Rep 14:17269","journal-title":"Sci Rep"},{"key":"12710_CR17","doi-asserted-by":"publisher","first-page":"107438","DOI":"10.1016\/j.vph.2024.107438","volume":"157","author":"W Zhang","year":"2024","unstructured":"Zhang W et al (2024) Functional characterization of human IL-8 in vascular stenosis using a novel humanized transgenic mouse model. Vascul Pharmacol 157:107438","journal-title":"Vascul Pharmacol"},{"key":"12710_CR18","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1161\/ATVBAHA.107.161240","volume":"28","author":"P Aukrust","year":"2008","unstructured":"Aukrust P et al (2008) Chemokines and Cardiovascular Risk. Arterioscler Thromb Vasc Biol 28:1909\u20131919","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"12710_CR19","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1093\/cvr\/cvp241","volume":"84","author":"S Apostolakis","year":"2009","unstructured":"Apostolakis S, Vogiatzi K, Amanatidou V, Spandidos DA (2009) Interleukin 8 and cardiovascular disease. Cardiovasc Res 84:353\u2013360","journal-title":"Cardiovasc Res"},{"key":"12710_CR20","doi-asserted-by":"publisher","first-page":"19108","DOI":"10.1038\/s41598-020-73600-4","volume":"10","author":"GV Paramel","year":"2020","unstructured":"Paramel GV et al (2020) Expression of CARD8 in human atherosclerosis and its regulation of inflammatory proteins in human endothelial cells. Sci Rep 10:19108","journal-title":"Sci Rep"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12710-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-12710-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12710-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T12:46:04Z","timestamp":1789735564000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-026-12710-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,18]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["12710"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-12710-0","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,18]]},"assertion":[{"value":"26 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":2,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Institutional Ethics Committee of Sri Ramachandra Institute of Higher Education and Research (SRIHER) ( (IEC No -NI\/22\/JAN\/81\/24).","order":3,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1592"}}